Results 221 to 230 of about 31,575,899 (247)

From evidence to care delivery: Opportunities and risks in health and science policy. A position paper of the Association of the Scientific Medical Societies in Germany (AWMF). [PDF]

Ger Med Sci
Wörmann B, Kopp I, Nothacker M, Klar E, Sedlmayr M, Vogeser M, Schliephake H, Treede RD.   +7 more
europepmc   +1 more source

Recapitulating In Vivo Pharmacokinetics and Size‐Dependent Nanomedicine Delivery in a Microfluidic Platform

Advanced Science, EarlyView.
A microfluidic tumor platform integrates pharmacokinetic flow control, vascular‐like barriers, and 3D tumor spheroids to emulate in vivo drug exposure. The system reproduces dynamic concentration–time profiles and enables size‐dependent nanoparticle transport and efficacy evaluation, providing a predictive framework for assessing nanomedicine ...
Su Jeong Kang, Moon Sup Yoon, Jae Min Lee, Min Jeong Jo, Chae Eun Jin, Dae Hwan Shin   +5 more
wiley   +1 more source

Advancing Clinical Research

Advanced Science, EarlyView.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy

Ca-A Cancer Journal for Clinicians, 2020
Carmen E Guerra, Kassandra I Alcaraz, Richard C Wender   +2 more
exaly  

Effectiveness factors and impacts on policymaking of science-policy interfaces in the environmental sustainability context

Environmental Science and Policy, 2023
Sara Velander, Niklas Wagner
exaly  

Public engagement with science—Origins, motives and impact in academic literature and science policy

PLoS ONE, 2021
Peter Weingart, Catherina Joubert, Karien Connoway   +2 more
exaly